Chiara
Chiara Abrescia, Torino IT
Patent application number | Description | Published |
---|---|---|
20130196924 | BIOMARKERS FOR DIAGNOSING AND DETECTING THE PROGRESSION OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF AMYOTROPHIC LATERAL SCLEROSIS - The present invention relates to biomarkers, to their use and to a method for diagnosing in vitro or detecting the progression of a neurodegenerative disease in an individual, in particular for Amyotrophic Lateral Sclerosis (ALS). The method comprises the steps of isolating a biological sample from the individual; quantifying the level of one or more polypeptides in the biological sample according to the invention; comparing the obtained level with a reference level. | 08-01-2013 |
Chiara Allegrini, Lucca IT
Patent application number | Description | Published |
---|---|---|
20090018517 | COMPOSITE ABSORBENT MATERIAL WITH WATER-SOLUBLE BONDING AGENTS, PRODUCTS MADE OF SAID MATERIAL NAD METHOD FOR ITS MANUFACTURE - A method is described for the manufacture of a composite absorbent material comprising the following stages: superabsorbent particles (P) are distributed on at least one first textile web (V | 01-15-2009 |
20090035515 | METHOD FOR PRODUCING A WEBLIKE PRODUCT FOR THE PRODUCTION OF ABSORBENT ITEMS AND SIMILAR, PRODUCT SO OBTAINED AND ABSORBENT ARTICLE INCLUDING SAID PRODUCT - A method for the production of a weblike material including a flocked substrate (F) is described, in which: on at least a first side of the substrate (F) is applied an adhesive (R); on said first face are distributed flock fibers ( | 02-05-2009 |
20090221982 | ELASTIC MATERIAL COATED IN FIBERS, A DIAPER COMPRISING SAID ELASTIC MATERIAL AND A METHOD FOR THE PRODUCTION THEREOF - The composite material comprises an elastic film (F), made of polymer material, and a coating made of flocked fibers ( | 09-03-2009 |
Chiara Azzari, Scandicci IT
Patent application number | Description | Published |
---|---|---|
20120273671 | METHOD AND KIT FOR DETERMINING METABOLITES ON DRIED BLOOD SPOT SAMPLES - A method for individuating with high sensitivity and specificity ADA metabolites from dried blood spot. The method described herein can be used to extract Adenosine and Deoxyadenosine from a sample under conditions that permit concurrently extracting other metabolites, such as amino acids, free carnitine, or acylcarnitines. For example, harsh extraction conditions (such as extreme acidity and high temperature) can be avoided. The method can be used, along with other neonatal screenings, on blood samples and preferably on dried blood spots (Guthrie cards) and more preferably on Guthrie cards obtained in the II-IV day of life. The method is reliable and reproducible, easy to perform and gives a definitive response within a short time (1-2 days). One or more kit for use in the method. | 11-01-2012 |
Chiara Azzari, Firenze IT
Patent application number | Description | Published |
---|---|---|
20100167272 | Method for Detecting and Analyzing Pathogens in a Sample - The present invention relates to a method and kits thereof for detecting the presence and/or the specific serogroup of a prokaryote selected from the group consisting of & | 07-01-2010 |
Chiara Bechini, Pisa IT
Patent application number | Description | Published |
---|---|---|
20090292129 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST - A process for resolving a compound in racemic form comprising the following steps is described: a) reacting a compound in racemic form with a resolving agent, b) forming a diastereoisomeric complex of the resolving agent and an enantiomer of interest, c) separating the enantiomer of interest from the obtained diastereoisomer, wherein such a process is characterized in that said resolving agent is a compound of Formula (I). A diastereoisomeric complex between the resolving agent of Formula (I) and the enantiomer of interest is also described. The process according to the invention allows acid and basic racemic mixtures to be separated. | 11-26-2009 |
Chiara Borsotti, Bronxville, NY US
Patent application number | Description | Published |
---|---|---|
20140134662 | GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF - Genetically modified non-human animals are provided that may be used to model human hematopoietic cell development, function, or disease. The genetically modified non-human animals comprise a nucleic acid encoding human IL-6 operably linked to an IL-6 promoter. In some instances, the genetically modified non-human animal expressing human IL-6 also expresses at least one of human M-CSF, human IL-3, human GM-CSF, human SIRPa or human TPO. In some instances, the genetically modified non-human animal is immunodeficient. In some such instances, the genetically modified non-human animal is engrafted with healthy or diseased human hematopoietic cells. Also provided are methods for using the subject genetically modified non-human animals in modeling human hematopoietic cell development, function, and/or disease, as well as reagents and kits thereof that find use in making the subject genetically modified non-human animals and/or practicing the subject methods. | 05-15-2014 |
Chiara Bovolenta, Milan IT
Patent application number | Description | Published |
---|---|---|
20080286248 | Hiv Vif Mutants - A polynucleotide comprising a nucleotide sequence encoding Vif, wherein each of the amino acids corresponding to positions 127, 128, 130, 131, 132 and 142 of the amino acid sequence in FIG. | 11-20-2008 |
20130164840 | Semi-Stable Production of Lentiviral Vectors - The present invention provides a new semi-stable packaging cell line and a method to produce lentiviral vectors (LV), using the semi-stable packaging cell line. New methods and packaging cell lines of the invention are generated using a baculo-AAV hybrid system for stable expression of structural and regulatory lentiviral proteins, such system comprising a baculoviral backbone containing an integration cassette flanked by AAV ITRs, in combination with a plasmid encoding rep protein. This system allows to obtain a stable integration of the structural and regulatory HIV-1 proteins gag/pol and rev. The system allows to obtain a cell line including the structural and regulatory HIV proteins gag/pol and rev, to be used for a semi-stable LV production. | 06-27-2013 |
20140051125 | Stable Production of Lentiviral Vectors - The present invention provides new stable packaging cell lines and producer cell lines as well as methods to obtain them, and a new method to produce lentiviral vectors using such cell lines. New methods and packaging cell lines of the invention are generated using a baculo-AAV hybrid system for stable expression of structural and regulatory lentiviral proteins, such system comprising a baculoviral backbone containing an integration cassette flanked by AAV ITR, in combination with a plasmid encoding rep protein. This system allows to obtain a stable integration of the structural and regulatory HIV-1 proteins gag/pol and rev. The system allows to obtain a first intermediate including only the structural and regulatory HIV proteins gag/pol and rev, to be used as starting point to obtain stable packaging cell lines as well as producer cell lines. | 02-20-2014 |
20140248695 | Viral Vectors Purification System - The present invention relates to a new method for purification of viral vectors particularly those belonging to the Retroviridae family, which is based on the expression in the packaging cell line that produced such vectors of an exogenous gene encoding a cell surface marker. The incorporation of the cell surface marker in the viral envelope of the vector allows purification with immunological methods. | 09-04-2014 |
Chiara Braconi, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20110250608 | USE OF ULTRACONSERVED RNA IN DETECTION AND TREATMENT OF CANCER - A method of analyzing a biological specimen to detect cancer in a subject, involving determining an ultraconserved RNA in the specimen and comparing the expression level to a control. The ultraconseved RNA may be uc.338 and may be used to detect hepatocellular cancer. Transcript RNA encoding ultraconserved RNA may also be used to detect cancer. Anti-cancer compositions and tumor-suppressing agents for treating cancer are also provided. | 10-13-2011 |
Chiara Busto, Trecate-Novara IT
Patent application number | Description | Published |
---|---|---|
20100184593 | METHOD TO ACTIVATE A CATALYST FOR A CONTINUOUS PROCESS FOR THE PREPARATION OF PHENOL FROM BENZENE IN A FIXED BED REACTOR - A process to activate a titanium silicalite catalyst for the oxidation of benzene to phenol is provided. The catalyst is activated in the reactor for the oxidation by feeding to a reactor containing the titanium silicalite catalyst, during a time of from 2 to 6 hours, at a temperature ranging from 20 to 120° C., an aqueous solution of ammonium acid fluoride in a concentration ranging from 0.1% to 1% by weight; and hydrogen peroxide in a concentration ranging from 3% to 10% by weight; feeding water to the reactor at the end of the reaction; and drying or calcining the catalyst contained in the reactor to obtain the activated catalyst. The catalyst is represented by the formula: | 07-22-2010 |
Chiara Cabrele, Regensburg DE
Patent application number | Description | Published |
---|---|---|
20120269837 | SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb) - This invention relates to novel immunogens carrying conformationally discriminating epitopes (CDEs) and to immunization methods for producing antibodies that specifically recognize proteins with very closely related homologues. In particular, the invention relates to antibodies which are specific for either FcγRIIb and FcγRIIa. | 10-25-2012 |
Chiara Cappellini, Erba (como) IT
Patent application number | Description | Published |
---|---|---|
20090114823 | RADIATION MEASURING DEVICE - A radiation measuring device to determine the intensity and/or the dose of the ionizing radiation during a radiological examination of a patient is provided, with the radiation measuring device ( | 05-07-2009 |
Chiara Casolari, Modena IT
Patent application number | Description | Published |
---|---|---|
20100048692 | Naphthofuranone Derivatives as Specific Inhibitors of Thymidylate Synthases - Synthetic compounds of 1,2-naphthalein moelcules (I) having specific inhibitory properties of the enzymatic activity of thymidylate synthases of bacterial species, their preparation, their pharmaceutical composition and use in the treatment and prophylaxis of infectious pathologies are disclosed. | 02-25-2010 |
Chiara Cerafogli, Avezzano IT
Patent application number | Description | Published |
---|---|---|
20130051149 | APPARATUSES AND METHODS OF REPROGRAMMING MEMORY CELLS - Apparatuses and methods for reprogramming memory cells are described. One or more methods for memory cell operation includes programming a number of memory cells such that each of the number of memory cells are at either a first program state or a second program state, the second program state having a first program verify voltage associated therewith; and reprogramming the number of memory cells such that at least one of the number of memory cells is reprogrammed to a third program state having a second program verify voltage associated therewith, wherein those of the number of memory cells having a threshold voltage less than the second program verify voltage represent a same data value. | 02-28-2013 |
20140126295 | APPARATUSES AND METHODS OF REPROGRAMMING MEMORY CELLS - Apparatuses and methods for reprogramming memory cells are described. One or more methods for memory cell operation includes programming a number of memory cells such that each of the number of memory cells are at either a first program state or a second program state, the second program state having a first program verify voltage associated therewith; and reprogramming the number of memory cells such that at least one of the number of memory cells is reprogrammed to a third program state having a second program verify voltage associated therewith, wherein those of the number of memory cells having a threshold voltage less than the second program verify voltage represent a same data value. | 05-08-2014 |
Chiara Cinelli, Barberino Di Mugello IT
Patent application number | Description | Published |
---|---|---|
20130152357 | TEST ARRANGEMENT FOR A CENTRIFUGAL COMPRESSOR STAGE - A system for testing a compressor is provided. The system comprises one or more compressors connected together in series to a test compressor wherein an output of the test compressor is connected to an input of a first compressor in the series, forming an overall loop, one or more process fluid coolers in the overall loop, one or more orifices in the overall loop, a control valve in the overall loop, and a first plurality of sensors configured adjacent to a process fluid input of the test compressor and a second plurality of sensors configured adjacent to a process fluid output of the test compressor. | 06-20-2013 |
Chiara Cometti, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20130057941 | ELECTROWETTING DISPLAY DEVICE - A method for making a support plate for an electrowetting device includes providing the support plate with a hydrophobic layer; arranging a pattern of hydrophilic material on the hydrophobic layer; and removing a surface layer of the hydrophobic layer by a solvent. The electrowetting device may include a support plate with a hydrophobic layer having a thickness, and a pattern of hydrophilic material arranged on a first area of the hydrophobic layer, the thickness of the hydrophobic layer being larger within the first area than outside the first area. | 03-07-2013 |
20140266992 | ELECTROWETTING DEVICE - A method of manufacturing a support plate for an electrowetting device includes providing a first hydrophobic layer on a substrate, reducing the hydrophobicity of a surface of the first hydrophobic layer and providing a second hydrophobic layer on at least part of the surface with reduced hydrophobicity. | 09-18-2014 |
Chiara Cundari, Pisa IT
Patent application number | Description | Published |
---|---|---|
20140141764 | INTEGRATED NUMBER MANAGEMENT MODULE AND SERVICE ORDER SYSTEM - A number inventory system is disclosed. The number inventory system manages the relationships between SIM cards, IMSI numbers, and MSISDN for a mobile telecommunications service provider. The number inventory system provides the software and hardware for receiving SIM card inventory data, including associated IMSI numbers, and efficiently stores the SIM card inventory data in a database. The number inventory system further provides for the opening of a range of available MSISDN. SIM cards, IMSI and MSISDN may be assigned to customer orders, and the number inventory system manages the associations between IMSI numbers and MSISDN and monitors the status of SIM cards, IMSI numbers and MSISDN. The number inventory system may also manage an MSISDN classification system for identifying MSISDN numbers having various desirable sequence characteristics. | 05-22-2014 |
Chiara Dalla Man, Venice IT
Patent application number | Description | Published |
---|---|---|
20100179768 | Method, System and Computer Simulation Environment for Testing of Monitoring and Control Strategies in Diabetes - A simulation environment for in silico testing of monitoring methods, open-loop and closed-loop treatment strategies in type 1 diabetes. Some exemplary principal components of the simulation environment comprise, but not limited thereto, the following: 1) a “population” of in silico “subjects” with type 1 diabetes in three age groups; 2) a simulator of CGM sensor errors; 3) a simulator of insulin pumps and discrete insulin delivery; 4) an interface allowing the input of user-specified treatment scenarios; and 5) a set of standardized outcome measures and graphs evaluating the quality of the tested treatment strategies. These components can be used separately or in combination for the preclinical evaluation of open-loop or closed-loop control treatments of diabetes. | 07-15-2010 |
Chiara Dalla Man, Venezia IT
Patent application number | Description | Published |
---|---|---|
20100262117 | PREDICTIVE CONTROL BASED SYSTEM AND METHOD FOR CONTROL OF INSULIN DELIVERY IN DIABETES USING GLUCOSE SENSING - A system and method for providing optimal insulin injections to a subject, using a controller, a continuous glucose monitor, and an insulin delivery unit is disclosed. The controller possesses a discrete-time, linear model predictive control law, means for sending information to the insulin delivery unit, and means for receiving information from the CGM. The control law implemented is derived from a discrete-time model of glucose insulin dynamics and an aggressiveness parameter. The result is that using only glucose measurements obtained from sensor readings and, prior values of external insulin infusion and meal and exercise announcement the optimal insulin injection necessary to safely regulate blood glucose can be calculated. | 10-14-2010 |
20120130698 | System, Method and Computer Simulation Environment For In Silico Trials in Pre-Diabetes and Type 2 Diabetes - An electronic system is provided that simulates a glucose-insulin metabolic system of a T2DM or prediabetic subject, wherein the system includes a subsystem that models dynamic glucose concentration in a T2DM or prediabetic subject, including an electronic module that models endogenous glucose production (EGP(t)), or meal glucose rate of appearance (Ra(t>>, or glucose utilization (U(t)), or renal excretion of glucose (B(t)), a subsystem that models dynamic insulin concentration in said T2DM or prediabetic subject, including an electronic module that models insulin secretion (S(t)), an electronic database containing a population of virtual T2DM or prediabetic subjects, each virtual subject having a plurality of metabolic parameters, and a processing module that calculates an effect of variation of at least one metabolic parameter value on the glucose insulin metabolic system of a virtual subject by inputting the plurality of metabolic parameter values. | 05-24-2012 |
20120245556 | System, Method and Computer Program Product For Adjustment of Insulin Delivery in Diabetes Using Nominal Open-Loop Profiles - A method, system and computer program product for correcting a nominal treatment strategy of a subject with diabetes. The method, system and computer program product may be configured for providing input whereby the input may include: open-loop therapy settings for the subject, data about glycemic state of the subject; and (optionally) data about meals and/or exercise of the subject. The method, system and computer program product may be configured for providing output, whereby the out-put may include an adjustment (correction) to the open-loop therapy settings for the subject for insulin delivery to the subject. | 09-27-2012 |
20130211220 | ESTIMATION OF INSULIN SENSITIVITY FROM CGM AND SUBCUTANEOUS INSULIN DELIVERY IN TYPE 1 DIABETES - In a method of determining insulin sensitivity in a patient, glucose level is sensed continuously. A first area under the curve representing the glucose level over time is calculated. An amount of insulin that has been administered to the patient is sensed. An estimation of insulin on board the patient is calculated based on the glucose level and the amount of insulin administered to the patient. A second area under the curve representing the insulin on board over time is calculated. Patient data indicative of at least one patient physical parameter is received. Information indicative of amount of glucose ingested by the patient during a meal is received. An insulin sensitivity output indicative of ability of insulin to stimulate glucose utilization and inhibit glucose production in the patient based on the first and second area under the curve, the patient data and the meal information is generated. | 08-15-2013 |
Chiara Dall'Ara, Masera' IT
Patent application number | Description | Published |
---|---|---|
20090030343 | Process for the production of interchangeable vacuum test tube holders for taking blood samples and product obtained therefrom - A process for the production of a tubular holder for vacuum test tubes and the holder obtained therefrom. The process includes the steps of inserting a straight needle into the holder and the subsequent bending of the needle, so that the outer end of the needle is first connected to the edge of a slanted support wall extending from the casing and has a terminal portion aligned with a side wall of the casing, thus facilitating the insertion of the needle into the limb of a patient. The new disposable holder is particularly useful for blood sampling because it provides for the alignment of the needle with respect to the patient's vein. | 01-29-2009 |
Chiara Daraio, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20090199643 | ACTUATION SYSTEM - A method and system for creating highly nonlinear solitary waves for use in performing nondestructive evaluation of structures and materials. The method and system use an apparatus having a spring loaded adjustable striker, a chain of granular particles, and a reloading device that allows for repeated activation of the adjustable striker. | 08-13-2009 |
20090204344 | METHOD AND APPARATUS FOR NONDESTRUCTIVE EVALUATION AND MONITORING OF MATERIALS AND STRUCTURES - A method and apparatus for nondestructive evaluation (NDE) of structures and materials using a highly nonlinear medium for the generation and detection of one or multiple highly nonlinear pulses (or highly nonlinear waves) impinging on a material or structure. The apparatus includes pulse exciters that induce the propagation of highly nonlinear, weakly nonlinear or linear stress waves in the material, system, or structure to be inspected and/or detectors for the observation and the detection of the output waves from the material/structure being tested. The NDE method includes the use of the tunable highly nonlinear apparatus as impulse exciter alone, or in combination with an accelerometer or a nonlinear sensor to detect the outgoing pulse. | 08-13-2009 |
20090229910 | METHOD AND SYSTEM FOR FORMATION OF HIGHLY NONLINEAR PULSES - A method and system supporting the formation and propagation of tunable highly nonlinear pulses using granular chains composed of non-spherical granular systems. Such a method and system may be used to support the creation of tunable acoustic band gaps in granular crystals formed of particles with different geometries (spherical or not) in which the tunability is achieved by varying the static precompression, type of excitation and/or pulse amplitude in the system. | 09-17-2009 |
20110209940 | SYSTEMS AND METHODS FOR CONTROLLING HIGHLY NONLINEAR ACOUSTIC WAVES OR PULSES - Systems and methods for creating sound bullets are described. Such sound bullets are created by controlling and/or redirecting highly nonlinear acoustic waves or pulses propagating through an array of actuators. The controlling and/or redirecting of the acoustic waves or pulses is achieved though methods such as applying pre-compressive forces to the array of actuators or by selection of size, shape and/or material of the actuators. | 09-01-2011 |
20120181104 | SYSTEM FOR FORMATION OF HIGHLY NONLINEAR PULSES - A system supporting the formation and propagation of tunable highly nonlinear pulses using granular chains composed of non-spherical granular systems. Such a system may be used to support the creation of tunable acoustic band gaps in granular crystals formed of particles with different geometries (spherical or not) in which the tunability is achieved by varying the static precompression, type of excitation and/or pulse amplitude in the system. | 07-19-2012 |
20130033339 | BIFURCATION-BASED ACOUSTIC SWITCH AND RECTIFIER - A tunable frequency acoustic rectifier that is a granular crystal composed of a statically compressed one-dimensional array of particles in contact, containing a light mass defect near a boundary. The tunable frequency acoustic rectifier is nonlinear and contains tunable pass and stop bands in their dispersion relation. Vibrations at selected frequencies applied to the granular crystal from the side near the defect will cause the system to bifurcate at a critical input amplitude and subsequently jump to quasiperiodic and chaotic states with broadband frequency content. Some of this frequency content lies within the pass bands and will propagate through the crystal. Vibrations at the same frequencies applied to the other side of the granular crystal will not bifurcate, and little energy is transmitted. | 02-07-2013 |
20130187094 | GRANULAR CRYSTAL - Granular crystals with one or more chains of particles are described. A geometry of at least one particle is chosen to provide highly nonlinear pulses having selected characteristics. Contact interactions between the particles are non-Hertzian. | 07-25-2013 |
20130220729 | METHOD AND APPARATUS FOR WAVE GENERATION AND DETECTION USING TENSEGRITY STRUCTURES - A tensegrity apparatus having multiple tensegrity units for the transmission of solitary waves with adjustable profiles into a material or structure, and the detection of such waves from a material or structure. | 08-29-2013 |
20130280515 | MULTILAYER FOAM STRUCTURES OF NOMINALLY-ALIGNED CARBON NANOTUBES (CNTS) - A method for making a multilayer foam structure of nominally-aligned carbon nanotubes (CNTs) is disclosed. The method comprises synthesizing a layer of CNTs and sandwiching the layer of CNTs between two polymeric layers, or between two metallic layers or foils. | 10-24-2013 |
20130301113 | DEFORMABLE MIRRORS AND METHODS OF MAKING THE SAME - A deformable mirror is configured to be deformed by surface-parallel actuation. In one embodiment, the deformable mirror includes a first piezoelectric active layer on a first surface of a substrate. The first piezoelectric active layer has a substantially uniform thickness across the first surface of the substrate. The mirror also includes a first electrode layer on the first piezoelectric active layer. The first electrode layer has a plurality of electrodes arranged in a first pattern and has a substantially uniform thickness across the first piezoelectric active layer. The mirror may further include a second piezoelectric layer on the first electrode layer, and a second electrode layer on the second piezoelectric layer. The electrodes of the first and second electrode layers are configured to supply a voltage to the piezoelectric active layers upon actuation to thereby locally deform the shape of the mirror to correct for optical aberrations. | 11-14-2013 |
20130302633 | THIN FILM BI-MATERIAL LATTICE STRUCTURES AND METHODS OF MAKING THE SAME - A micro-scaled bi-material lattice structure includes a frame comprising a first material having a first coefficient of expansion and defining a plurality of unit cells. The bi-material lattice structure further includes a plurality of plates comprising a second material having a second coefficient of expansion different from the first coefficient of expansion. One of the plates is connected to each unit cell. The bi-material lattice structure has a third coefficient of expansion different from both the first coefficient of the expansion and the second coefficient of expansion, and the bi-material lattice structure has a thickness of about 100 nm to about 3000 microns. | 11-14-2013 |
20140011007 | CARBON NANOTUBE FOAMS WITH CONTROLLABLE MECHANICAL PROPERTIES - Syntheses of carbon nanotubes (CNT) are disclosed. The syntheses can take place on a thermally oxidized silicon surface placed inside a furnace prior to a reaction. The setup can have many variables that could affect the resulting CNT arrays, including flow rate and composition of carrier gas, flow rate and composition of precursor solution, and temperature. By varying such variables the density of the resulting CNT arrays can be controlled. | 01-09-2014 |
20140097562 | TUNABLE PASSIVE VIBRATION SUPPRESSOR - An apparatus and method for vibration suppression using a granular particle chain. The granular particle chain is statically compressed and the end particles of the chain are attached to a payload and vibration source. The properties of the granular particles along with the amount of static compression are chosen to provide desired filtering of vibrations. | 04-10-2014 |
20140205829 | METHOD FOR CONTROLLING MICROSTRUCTURAL ARRANGEMENT OF NOMINALLY-ALIGNED ARRAYS OF CARBON NANOTUBES - A method for controlling the microstructural arrangement of nominally-aligned arrays of carbon nanotubes (CNTs) and a foam structure of CNTs are disclosed. The method includes a functionalization of CNT surfaces, for example, a non-covalent functionalization. The non-covalent functionalization of CNT surfaces can be obtained by way of a wetting process, for example by the use of a solution of surfactant or silica (SiO | 07-24-2014 |
20140245522 | SOUND PROOF HELMET - Novel methods and systems for acoustic proofing are disclosed. A sound proof helmet can be designed by optimizing several layers of different materials, thickness, and physical properties. The thickness of the layers can be smaller than the wavelength of the sound waves which are meant to be reduced. | 09-04-2014 |
Chiara De Gregorio, Cori(latina) IT
Patent application number | Description | Published |
---|---|---|
20100113403 | COMPOSITIONS CONTAINING COMPOUNDS HAVING STEROID STRUCTURE AND THEIR USE FOR INDUCING THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS OF THE ORGANISM - Use of a mixture of phytosterols, selected from the group comprising: brassicasterol (Delta 5-C22 unsaturated); campesterol; campestanol; stigmasterol (Delta 5-C22 unsaturated); Delta 5-C23-stigmastadienol; clerosterol (Delta 8-C25 unsaturated); Beta-sitosterol; sitostanol; Delta 5-venasterol (Delta 5-C24 unsaturated); Delta 5-C24-stigmastadienol (Delta 5-C24 diene unsaturated); Delta 7-stigmastenol; 24-methylene-cycloartenol; gramisterol; 24-methylcholest-7-enol; isofucosterol; Delta 7-avenasterol (Delta 7-C24 unsaturated); Delta 5-avenastenol, for the manufacture of a medicament to induce into the adult organism proliferation and differentiation of the stem cells which are present in the organism. | 05-06-2010 |
Chiara Del Sarto, Torino IT
Patent application number | Description | Published |
---|---|---|
20120090762 | ADHESIVE ELEMENT FOR ADHESION TESTS AND CORRESPONDING TESTING PROCESS - An adhesive element for adhesion tests, comprising a bi-adhesive layer including a first adhesive surface, designed to co-operate in a relation of adhesion with a surface undergoing testing, and a second adhesive surface. The adhesive element further comprises a support layer having a comparative adhesion surface designed to co-operate in a relation of adhesion with the second adhesive surface. The bi-adhesive layer has a fragmented structure. | 04-19-2012 |
Chiara De Martini, Milano IT
Patent application number | Description | Published |
---|---|---|
20110025383 | METHOD OF ENHANCING POWER SAVING IN AN INTEGRATED ELECTRONIC SYSTEM WITH DISTINCTLY POWERED ISLANDS OF FUNCTIONAL CIRCUITRIES AND RELATED DEVICE ARCHITECTURE - A method for power saving in an integrated circuit device may include defining an off-switchable analog circuit island including an internal clock generating circuit, and at power-on of the integrated circuit device, supplying to clocked digital circuits of the integrated circuit device an auxiliary clock from the external controller. The auxiliary clock has a frequency determined by the external controller and being lower than the root clock signal. The method includes supplying external reset commands to the integrated circuit device until an active functioning condition of the integrated circuit device is asserted, and interrupting the supply of the auxiliary clock and enabling supply of the root clock signal to the clocked digital circuits when the active functioning condition of the integrated circuit device is asserted. | 02-03-2011 |
Chiara Dionigi, Bologna IT
Patent application number | Description | Published |
---|---|---|
20090017284 | DEVICE COMPRISING A CHARGE TRANSFER CHANNEL AND METHOD FOR MANUFACTURING THE SAME - A device comprising a charge transfer channel, wherein the charge transfer channel comprises a composite material which comprises particles of a dielectric material with interstice voids between them which are partially or totally infilled by a semiconductor or conductor material. | 01-15-2009 |
Chiara Domini, Udine IT
Patent application number | Description | Published |
---|---|---|
20140293630 | Automotive Light - An automotive light is provided that includes a light-guide bar made of photoconductive-material, which is at least partially positioned substantially grazing a corresponding transparent or semitransparent portion of the front lenticular half-shell of the light, and a second light source which is structured so as to emit light when electricity powered, and is arranged inside the rear body, close to one end of the light-guide bar, so as to direct the light produced inside the body of said light-guide bar. The light-guide bar is provided with a longitudinal light-extractor band which extends along the lateral side of the bar, and a multitude of deflector prisms which have an approximately triangle-shaped cross-section and are conveniently arranged along the longitudinal light-extractor band. One or more deflector prisms are shaped so that the active deflector surface has a bulging/arched profile substantially over the whole width of the longitudinal band. | 10-02-2014 |
Chiara Falciani, Siena IT
Patent application number | Description | Published |
---|---|---|
20110190198 | PEPTIDE SEQUNCES, THEIR BRANCHED FORM AND USE THEREOF FOR ANTIMICROBIAL APPLICATIONS - The present invention relates to an antibacterial peptide having from the amino to the carboxylic terminal an amino acid sequences selected from the group of: KKIRVRLSA, SEQ ID NO. 1, RRIRVRLSA, SEQ ID NO. 2, KRIRVRLSA, SEQ ID NO. 3, RKIRVRLSA, SEQ ID NO. 4 or a derivative thereof and uses thereof. | 08-04-2011 |
20110319339 | NEUROTENSIN-DERIVED BRANCHED PEPTIDES AND USES THEREOF - The present invention relates to a multimeric molecule having the general formula A or B: | 12-29-2011 |
20130130969 | ANTIMICROBIAL PEPTIDE, BRANCHED FORMS THEREOF AND THEIR USE IN THE TREATMENT OF BACTERIA INFECTIONS - The instant invention refers to an antibacterial peptide with all aminoacids in D-configuration, possessing strong antimicrobial activity against Gram-negative and Gram-positive bacteria and | 05-23-2013 |
Chiara Fanali, Roma IT
Patent application number | Description | Published |
---|---|---|
20110079076 | MOLECULAR MARKERS FOR AUTISM - The invention relates to the determination of phosphorylation levels of some specific salivary peptides (statherin, histatin 1, acidic proline-rich proteins, both in whole form (PRP-1 type) and in truncated form (PRP-3 type) as a non-invasive diagnostic marker with a >40% sensitivity for defining autism spectrum disorders (ASDs) patients, methods for performing said determination, a kit for the non-invasive diagnosis of at least 40% of autism cases, containing means for such a determination, and the use of such a determination for therapeutical research on autism. | 04-07-2011 |
Chiara Ferrandi, Moncalieri IT
Patent application number | Description | Published |
---|---|---|
20090176762 | JNK Inhibitors for Treatment of Skin Diseases - This invention relates to the use of a JNK inhibitor for treating and/or preventing skin diseases selected from psoriasis and dermatitis. | 07-09-2009 |
Chiara Garbolino, Vlaardingen NL
Patent application number | Description | Published |
---|---|---|
20080268130 | Edible fat continuous spreads - The invention relates to an edible fat continuous spread comprising from 5 to 85 wt % fat and from 0.1 to 20 wt % plant sterol wherein the plant sterol is present in the form of elongated crystals. The invention further relates to a process for the preparation of an edible fat continuous spread comprising plant sterol, said process comprising the mixing of a first mixture comprising triglyceride oil and plant sterol present in the form of elongated crystals with a second mixture comprising one selected from the group consisting of fat phase, water phase and mixtures thereof, to provide a third mixture. | 10-30-2008 |
20090041898 | Food product comprising bacteria and sorbitan fatty acid - Food product comprising live food grade bacterium and sorbitan fatty acid ester. It was surprisingly found that sorbitan fatty acid ester enhances the viability of bacteria in food products. | 02-12-2009 |
20090136645 | Granules Comprising Sterol - Granule comprising lipid powder particles having a microporous structure and comprising sterol. | 05-28-2009 |
Chiara Garbolino, At Vlaardingen NL
Patent application number | Description | Published |
---|---|---|
20090017163 | Composition comprising bacteria and lecithin - The present invention relates to a composition comprising live food grade bacterium and lecithin wherein the water activity of the composition is at least 0.5 and the amount of fat is between 10 and 80 wt %. It was surprisingly found that lecithin enhances the viability of bacteria in compositions. | 01-15-2009 |
Chiara Gualandi, Molinella (bologna) IT
Patent application number | Description | Published |
---|---|---|
20130209534 | Substrate Of Polymeric Material And Method Of Carrying Out Thereof - A substrate of polymeric material for wound care contains at least one oleous antimicrobial and/or helping tissue regeneration substance that is selected from Hyperforin, Adhyperforin, 1-3 Diapigenin, 11-8 Diapigenin, Rutin, Quercetin, Hypericin, Azadirachtin α-β, Nimbin, Nimbidin, Salanin, Gallic Acid, Gedunin and combinations thereof. | 08-15-2013 |
Chiara Liberati, L`aquila IT
Patent application number | Description | Published |
---|---|---|
20140371274 | BRADYKININ RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The present invention relates to novel compounds, their use in the prevention or treatment of symptoms and disorders associated with the bradykinin B | 12-18-2014 |
Chiara Liberati, Milano IT
Patent application number | Description | Published |
---|---|---|
20140031398 | TRPM8 RECEPTOR ANTAGONISTS - Compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (hereinafter referred to as TRPM8), having formula: | 01-30-2014 |
Chiara Liberati, Via Olgettina 58 IT
Patent application number | Description | Published |
---|---|---|
20140371276 | TRPM8 ANTAGONISTS - The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exhacerbated respiratory disorders and urological disorders. | 12-18-2014 |
Chiara Lorenzetto, Villafranca Piemonte IT
Patent application number | Description | Published |
---|---|---|
20090324677 | POLYMER CONJUGATES OF BOX-A OF HMGB1 AND BOX-A VARIANTS OF HMGB1 - The present invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A (HMGB1 Box-A) or of a biologically active fragment of HMGB1 Box-A. Further, the invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A (HMGB1 Box-A). Moreover, the present invention concerns the use of said polymer conjugates of polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1 and/or associated with an increased expression of RAGE. | 12-31-2009 |
20110052493 | USE OF POLYPEPTIDES OBTAINED THROUGH SYSTEMATIC MUTATIONS OF SINGLE AMINO ACIDS OF HUMAN AND NON-HUMAN BOX-A OF HMGB1 TO PREVENT AND/OR ANTAGONIZE PATHOLOGIES INDUCED BY HMGB1 - The present invention relates to polypeptide variants of the HMGB-1 high affinity binding domain Box-A (HMGB1 Box-A) or to a biologically active fragment of HMGB1 Box-A, which are obtained through systematic mutations of single amino acids of the wild-type HMGB1 Box-A protein and which show an increased resistance to proteases and which are therefore characterized by more favourable pharmacokinetic and pharmacodynamic profiles. Moreover, the present invention concerns the use of said polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1 and associated with RAGE. | 03-03-2011 |
20140065094 | POLYMER CONJUGATES OF BOX-A OF HMGB1 AND BOX-A VARIANTS OF HMGB1 - The present invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A (HMGB1 Box-A) or of a biologically active fragment of HMGB1 Box-A. Further, the invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A (HMGB1 Box-A). Moreover, the present invention concerns the use of said polymer conjugates of polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1 and/or associated with an increased expression of RAGE. | 03-06-2014 |
Chiara Lorenzetto, Torino IT
Patent application number | Description | Published |
---|---|---|
20110311451 | SYNTHESIS OF POLYMER CONJUGATES OF INDOLOCARBAZOLE COMPOUNDS - The present invention relates to a process for the preparation of polymer conjugates of iπdolocarbazole compounds, in particular of polymer conjugates of K-252a and derivatives thereof, by a synthetic route which results in a highly pure product, with a high product yield. In a further aspect the present invention relates to novel polymer conjugates of K-252a and derivatives thereof, wherein the chemical group linking the polymer unity to the K-252a or to the K-252a derivative compound is characterised by a 5-member oxazolidindionic cyclic structure. These novel polymer conjugates are obtained through the novel synthetic route with high purity and high yields, | 12-22-2011 |
Chiara Malvolti, Parma IT
Patent application number | Description | Published |
---|---|---|
20100098642 | OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION - The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium | 04-22-2010 |
20110212912 | OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION - The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium | 09-01-2011 |
20120184502 | OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION - The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium | 07-19-2012 |
Chiara Marinzi, Bresso IT
Patent application number | Description | Published |
---|---|---|
20120253043 | NOVEL LIGANDS FOR SENSITIZING DYES OF DYE-SENSITIZED SOLAR CELLS - The present invention provides new bi- and polypyridine ligands of ruthenium dyes. The invention also provides solar cells, in particular dye-sensitized solar cells comprising the dyes. | 10-04-2012 |
Chiara Martinelli-Cattaneo, Sergy FR
Patent application number | Description | Published |
---|---|---|
20080291888 | Method and Device for Carrying Out Flexible Demodulation in an Ofdm-Cdma System - This method for carrying out the flexible demodulation of data modulated following an amplitude modulation in quadrature is used in a communications system employing a code division multiple access technique (CDMA) and an optical frequency division multiplexing (OFDM) using non-binary spread codes. The invention includes steps for determining a simplified expression specific to the logarithm of the likelihood ratio. | 11-27-2008 |
20090296784 | METHOD AND DEVICE FOR NOTCHING THE TRANSMISSION BAND OF AN ANALOG SIGNAL, IN PARTICULAR FOR A DETECT AND AVOID (DAA) OPERATION MODE OF AN MB-OFDM SYSTEM - A transmission band of an analog signal including successive symbols to be transmitted is notched, where each symbol includes sub-carriers to be modulated. In particular, in each symbol the sub-carriers corresponding to a part of the transmission band to be notched are suppressed. In addition, in each symbol a chosen part of the remaining sub-carriers to be modulated is also suppressed. | 12-03-2009 |
Chiara Mingardi, Vicenza IT
Patent application number | Description | Published |
---|---|---|
20110138032 | METHOD FOR MANAGING A NETWORK AND A NETWORK - For providing a significant reduction of resource consumption and network traffic within a network a method for managing a network is claimed, the network including: a plurality of network elements, each of which being able to run at least one network management function and to store management information being necessary for running the at least one management function, the method being characterized by randomly activating and deactivating the at least one management function on one or more of the network elements by a randomization process. Further, an according network is claimed, preferably for carrying out the above mentioned method. | 06-09-2011 |
Chiara Missiroli, Concorezo (mb) IT
Patent application number | Description | Published |
---|---|---|
20120230108 | MEMORY DEVICE WITH MULTIPLE PLANES - Disclosed herein is a device that comprises at least one selection/non-selection voltage receiving line, at least one word line operatively coupled to the selection/non-selection voltage receiving line, and a plurality of memory cells coupled to the word line; a selection voltage source line; and a selection voltage supply circuit comprising a first switch circuit and a first driver circuit driving the first switch circuit to be turned ON or OFF, the first switch circuit including a first node coupled to the selection voltage source line, a second node coupled to the selection/non-selection voltage receiving line of the first memory plane and a third node coupled to the selection/non-selection voltage receiving line of the second memory plane, and the first driver circuit being provided in common to the first and second memory planes. | 09-13-2012 |
Chiara Missiroli, Concorezzo IT
Chiara Missiroli, Concorezzo (mb) IT
Patent application number | Description | Published |
---|---|---|
20130069715 | PSRR IN A VOLTAGE REFERENCE CIRCUIT - Devices and circuits for voltage reference architectures that can increase the PSRR parameter by improving the saturation margin for an output transistor. For example, a device can include a current source coupled between a first power supply line and a circuit node, a voltage production circuit coupled between the circuit node and a second power supply line to produce a plurality of voltages respectively at voltage nodes thereof, a multiplexer coupled to the voltage nodes of the voltage production circuit and the output node and configured to select and output one of the voltages to the output node, and a control circuit configured to supply the one of the voltages to the circuit node. | 03-21-2013 |
20130242671 | VOLTAGE REGULATOR FOR BIASING A NAND MEMORY DEVICE - Disclosed herein is a device that includes an amplifier, a first transistor coupled between the first power supply line and the internal node and including a gate terminal supplied with a bias voltage, a second transistor coupled between the internal node and the second power supply line and including a gate terminal coupled to the output terminal of the amplifier, a third transistor coupled between the first power supply line and the output node and including a gate terminal coupled to the internal node, a divider configured to produce a first discharge path from the output node to the second power supply line to establish the feedback voltage to the amplifier, and a first switch circuit supplied with a first signal and coupled between the output node and the internal node. | 09-19-2013 |
20130294170 | SWITCH AND SEMICONDUCTOR DEVICE INCLUDING THE SWITCH - A device includes a first transistor coupled between first and second nodes, and including a control gate supplied with a first control signal, a second transistor coupled between the first node and a third node, and including a control gate supplied with the first control signal, a third transistor coupled between the third node and a fourth node, and including a control gate supplied with a second control signal, a fourth transistor coupled between the fourth node and a fifth node, and including a control gate supplied with the second control signal, and a fifth transistor coupled between the fifth node and the second nodes, and including a control gate supplied with the first control signal. Each of the second and fifth transistors is smaller in threshold voltage than the first transistor. | 11-07-2013 |
20140071760 | SYSTEMS AND METHODS FOR ERASING CHARGE-TRAP FLASH MEMORY - FLASH memory device contains at least one memory stack. The stack of transistors includes a first (or source) selector transistor, a second (or drain) selector transistor, and a plurality memory cell transistors connected in series therebetween. During an erase operation, each of the first and second selector transistors has a bias applied that releases the select transistors from an electrically floating state together with biasing each of the memory cell transistors. | 03-13-2014 |
Chiara Missiroli, Concorezzo (mi) IT
Patent application number | Description | Published |
---|---|---|
20130301361 | ROW DRIVER ARCHITECTURE - Devices and circuits for row driver in a memory device. The proposed row driver circuit architectures may reduce size of the row driver circuitry and enhance the row driver circuit's reliability. Specifically, the proposed embodiments of the row driver may reduce the required sizing of the boosting capacitor or alternatively eliminate the boosting capacitor entirely. Further, the embodiments of the row driver may reduce the risk of charge-leakage on K-nodes, enhancing the row driver's reliability in driving the x-path of the memory array. | 11-14-2013 |
20140369125 | SEMICONDUCTOR DEVICE, DATA PROGRAMMING DEVICE, AND METHOD FOR IMPROVING THE RECOVERY OF BIT LINES OF UNSELECTED MEMORY CELLS FOR PROGRAMMING OPERATION - A device comprises a non-volatile memory array, a first selection circuit selecting whether to make a first connection path between a first bit line and a first circuit node, and selecting whether to make a second connection path between the first bit line and a second circuit node, a power supplying circuit supplying a power supply voltage to the first circuit node, the power supply voltage being, when the first connection path is selected to be made, supplied to the first bit line, and a first voltage supplying circuit supplying a first voltage to the second circuit node, the first voltage being, when the second connection path is selected to be made, supplied to the first bit line, the first voltage and the power supply voltage being higher than a ground potential, and the first voltage being higher than the power supply voltage. | 12-18-2014 |
Chiara Parlati, Parma IT
Patent application number | Description | Published |
---|---|---|
20110097409 | PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-Q- UINOLINONE HAVING IMPROVED ADHESION PROPERTIES FOR POWDER FORMULATIONS FOR INHALATION - Powder particles comprising a pharmaceutically acceptable salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone (carmoterol) having a specific properties exhibit improved adhesion properties for dry powder formulations for inhalation. Such particles are useful for formulations in the form of powders for inhalation and the treatment of certain conditions and diseases. | 04-28-2011 |
Chiara Pezzoni, Cassina De' Pecchi (mi) IT
Patent application number | Description | Published |
---|---|---|
20130087450 | ELECTRODE FOR ELECTROCHLORINATION - The invention relates to an electrode for electrochemical generation of hypochlorite. The electrode comprises a valve metal substrate coated with a catalytic system consisting of two super-imposed layers of distinct composition and having a different activity towards hypochlorite anodic generation from chloride solutions. The electrode has a high duration in cathodic operation conditions, imparting self-cleaning characteristics thereto when used in combination with an equivalent one with periodic polarity reversal. Moreover, the deactivation of the electrode at the end of its life cycle occurs in two subsequent steps, allowing to schedule the substitution thereof with a significant notice period. | 04-11-2013 |
20130186750 | ANODE FOR ELECTROLYTIC EVOLUTION OF CHLORINE - An electrode suitable for chlorine evolution in electrolysis cells consists of a metal substrate coated with two distinct compositions applied in alternate layers, the former comprising oxides of iridium, ruthenium and valve metals, for instance tantalum, and the latter comprising oxides of iridium, ruthenium and tin. | 07-25-2013 |
Chiara Piglione, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090010162 | Flexible and hierarchical dynamic buffer allocation - In one embodiment, a method comprises the following steps: receiving a first set of inputs comprising a first plurality of entities and a first traffic behavior; determining a first region of a buffer corresponding to the first traffic behavior; assigning the first plurality of entities to the first region; determining hierarchical relationships between at least some of the first plurality of entities; determining a first shared buffer space of the first region; and assigning at least one threshold for each of the first plurality of entities. The threshold may comprise a maximum amount of the first shared buffer space that may be allocated to an entity. The method may also involve configuring a logic device to allocate the first shared buffer space dynamically according to the hierarchical relationships and the thresholds. | 01-08-2009 |
20100296398 | Apparatus and Methods for Hybrid Fair Bandwidth Allocation and Drop Precedence - In one embodiment, apparatus and methods for apparatus and methods for fair bandwidth allocation are disclosed. In one embodiment, a method includes (i) determining a drop probability for each of a plurality of classes of packets being dropped or admitted to a queue, wherein each drop probability is based on a weighted fair bandwidth allocation process that is performed with respect to the plurality of classes and a plurality of packet arrival rates and predefined weights for such classes; and (ii) dropping a particular packet or admitting such particular packet to the queue based on the drop probability for such particular packet's class, wherein such dropping or admitting operation is further based on one or more drop precedence factors that are also determined periodically for each class if such one or more drop precedence factors are selected for such each class. In other embodiments, the invention pertains to an apparatus having one or more processors and one or more memory, wherein at least one of the processors and memory are adapted for performing the above described method operations. | 11-25-2010 |
20130329577 | SYSTEM AND METHOD FOR DISTRIBUTED RESOURCE CONTROL OF SWITCHES IN A NETWORK ENVIRONMENT - An example method includes sending a virtual output queue (VOQ) length of a VOQ to an egress chip. The VOQ relates to a flow routed through an egress port associated with the egress chip. The method also includes receiving fair share information for the VOQ from the egress chip, and enforcing a control action on the incoming packets based on the fair share information. An ingress chip and the egress chip can be provided in a VOQ switch. The control action is a selected one of a group of actions, the group consisting of: (a) dropping packets, (b) pausing packets, and (c) marking packets. The method can further include receiving VOQ lengths of corresponding VOQs from respective ingress chips, where the VOQs relate to the flow. The method can also include calculating respective fair share information for each VOQ, and sending the fair share information to the respective ingress chips. | 12-12-2013 |
20140161135 | Output Queue Latency Behavior For Input Queue Based Device - In one implementation, an input queue switch provides latency fairness across multiple input ports and multiple output ports. In one embodiment, each input port maintains a virtual output queue for each associate output port. The virtual output queues across multiple inputs are aggregated for each specific output port. The sum of the lengths of the virtual output queues is compared to a threshold, and based on the comparison, feedback may be generated to control the operation of the input port for subsequent packets. The feedback may instruct the input port to stop buffering or drop packets destined for the output port with the sum of the lengths of the virtual output queues associated to the specific output port that exceeds the threshold. In another embodiment, each packet has an arrival timestamp, and a virtual output queue having the oldest timestamp is selected first to dequeue. | 06-12-2014 |
20140328175 | UTILIZING LATENCY CONTROL TO ALLEVIATE BUFFERBLOAT - In one embodiment, a method includes estimating a current queuing latency, the estimated current queuing latency being associated with a queue of packets maintained in a buffer. The method also includes calculating a current drop or mark probability, the current drop or mark probability being associated with a probability that packets associated with the queue of packets will be dropped or marked. A rate at which the packets associated with the queue of packets are dequeued from the buffer is estimated in order to estimate the current queuing latency. The current drop or mark probability is calculated using the current estimated queuing latency. | 11-06-2014 |
Chiara Regale, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20090010265 | Flexible mapping of virtual local area networks to Ethernet virtual circuits - A method includes configuring multiple Ethernet Virtual Circuits (EVCs) for communicating with respective service gateways that provide respective communication services. A data packet, which belongs to a Virtual Local Area Network (VLAN) and is associated with a communication service from among the communication services, is accepted. The data packet is mapped to an EVC from among the multiple EVCs responsively to the VLAN to which the data packet belongs and to the communication service with which the data packet is associated. The data packet is sent over the EVC to the service gateway, in order to provide the communication service. | 01-08-2009 |
Chiara Rodighiero, Essex GB
Patent application number | Description | Published |
---|---|---|
20100111768 | SYSTEMS AND DEVICES FOR SEQUENCE BY SYNTHESIS ANALYSIS - The present invention comprises systems and devices for sequencing of nucleic acid, such as short DNA sequences from clonally amplified single-molecule arrays. | 05-06-2010 |
Chiara Sabbione, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20140342528 | METHOD FOR THE DIRECT BONDING OF A SILICON OXIDE LAYER - A direct bonding method between at least a first layer ( | 11-20-2014 |
Chiara Savardi, Sesto San Giovanni (milano) IT
Patent application number | Description | Published |
---|---|---|
20080213970 | PROCESS FOR THE FORMATION OF DIELECTRIC ISOLATION STRUCTURES IN SEMICONDUCTOR DEVICES - A process for forming a dielectric isolation structure on a silicon substrate includes forming at least one trench in the substrate, performing a high-temperature treatment in an oxidizing environment to form a first liner layer of silicon dioxide on the walls and the bottom of the trench, and performing a silicon dioxide deposition treatment to form a second liner layer on the first liner layer. A silicon nitride deposition treatment is also performed to form a third liner layer on the second liner layer. The trench is filled with isolating material. | 09-04-2008 |
Chiara Schiraldi, Pambio-Noranco CH
Patent application number | Description | Published |
---|---|---|
20130225802 | PROCESS FOR OBTAINING CHONDROITIN SULPHATED AT THE 4- OR 6- POSITIONS OF N-ACETYL-GALACTOSAMINE RESIDUES - Disclosed is a process for the production of chondroitin sulphate, wherein N-acetyl-galactosamine residues sulphated at the 4- or 6-positions are present on the same polysaccharide chain. | 08-29-2013 |
Chiara Schiraldi, Napoli IT
Patent application number | Description | Published |
---|---|---|
20120135470 | BIOTECHNOLOGICAL PRODUCTION OF CHONDROITIN - An innovative method is described for the production of chondroitin at high concentration, by fermentation of genetically mutated bacteria. | 05-31-2012 |
20130165404 | HYBRID COOPERATIVE COMPLEXES OF HYALURONIC ACID - Describes cooperative hybrid complexes of hyaluronic acid, a simple and economical method for production thereof and use thereof in the area of medicine, cosmetics and food. | 06-27-2013 |
Chiara Schivalocchi, Roe' Volciano IT
Patent application number | Description | Published |
---|---|---|
20090071326 | Piston For Cold Chamber Die-Casting Machine - The object of the present invention is a piston for cold chamber die-casting machines comprising a body and at least one sealing band mounted around said body, wherein said body and said band are provided with coupling means suitable for concurrently obtaining both an angular locking and an axial locking of the band to the piston body. | 03-19-2009 |
20140123848 | PISTON FOR A DIE-CASTING MACHINE - A piston for a die-casting machine, in particular with a cold chamber, comprises a stem which extends from a proximal end to a distal end along a piston axis and a piston head which extends from the distal end of the stem and which has a side wall with at least one sealing area suitable to form a seal on the wall of said container of the press. A lubrication circuit suitable for favouring the sliding of the piston comprises first lubrication ducts made in the stem and ending at the distal end of said stem, and second ducts made in the piston head, fluidically communicating with said first ducts and coming out in the lateral wall at least in correspondence with said sealed area. | 05-08-2014 |
Chiara Stringari, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20120276578 | Phasor Method to Fluorescence Lifetime Microscopy to Discriminate Metabolic State of Cells in Living Tissue - “A label-free imaging method to monitor stem cell metabolism discriminates different states of stem cell as they differentiate in a living tissues. We use intrinsic fluorescence biomarkers and the phasor approach to Fluorescence Lifetime Imaging Microscopy (FLIM). We identify and map intrinsic fluorophores such as collagen, retinol, retinoic acid, flavins, nicotinamide adenine dinucleotide (NADH) and porphyrin. We measure the phasor values of germ cells in | 11-01-2012 |
Chiara Tonda Turo, Carignano (torino) IT
Patent application number | Description | Published |
---|---|---|
20130165957 | Implantable Prosthetic Devices and Solvent-Casting Methods for Manufacturing Same - Implantable prosthetic devices are provided. Such devices include substantially planar supports such as a mesh for surgical use made of polypropylene, and a porous coating membrane formed on at least one face of said support, said porous membrane being formed in situ on the support by the solvent casting technique. Methods for making such prosthetic devices are also provided. | 06-27-2013 |
Chiara Vitale Brovarone, Torino IT
Patent application number | Description | Published |
---|---|---|
20100179662 | MONOBLOCK CERAMIC PROSTHESIS DEVICES - Single-piece prosthesis elements chosen from among acetabular cup for hip prosthesis, tibial component and femoral component for knee prosthesis, comprising a body ( | 07-15-2010 |
20130059013 | INJECTABLE OSTEOINDUCTIVE BONE CEMENTS - An injectable composition for bone filling or consolidation, for use in surgery or therapy, characterized in that it comprises a biocompatible powdery material, which is hardenable or cross-linkable and selected from calcium sulphate hemi-hydrate and polymethylmethacrylate, a hardening or cross-linking agent for said material and a porous silica-based powdery material, having a specific surface area higher than 100 m | 03-07-2013 |
Chiara Vladiskovic, Milano IT
Patent application number | Description | Published |
---|---|---|
20090062534 | LINEZOLID CRYSTALLINE HYDRATE FORM AND LINEZOLID SALTS - Linezolid salts, useful as such and as intermediates in a process for the preparation of novel and known crystalline linezolid forms, in particular known as Form III. | 03-05-2009 |
20090203915 | Process for the preparation of solifenacin - A process for the preparation of (1S,3′R)-quiniclidin-3′-yl-1-phenyl-3,4-dihydro-1H-isoquinolin-2-carboxylate, namely solifenacin, comprising the reaction of a compound of formula (IV) with a compound of formula (V), as herein defined, | 08-13-2009 |
20100204479 | CRYSTALLINE FORMS OF DEXLANSOPRAZOLE - The present invention relates to novel crystalline forms of Dexlansoprazole and a process for the preparation of amorphous Dexlansoprazole. | 08-12-2010 |
20110028728 | PROCESS FOR THE PREPARATION OF CRYSTALLINE DEXLANSOPRAZOLE - Process for the preparation of crystalline anhydrous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroetoxy)-2-piridyl]methyl]sulphinyl]benzimidazole (dexlansoprazole). | 02-03-2011 |
20110034523 | CRYSTALLINE FORMS OF RUFINAMIDE - Disclosed is a crystalline form of rufinamide selected from: | 02-10-2011 |
Chiara Vladiskovic, Baranzate (mi) IT
Patent application number | Description | Published |
---|---|---|
20140058107 | APIXABAN PREPARATION PROCESS - Process for the preparation of apixaban and intermediates useful for the preparation thereof. | 02-27-2014 |
Chiara Zambetti, Baden CH
Patent application number | Description | Published |
---|---|---|
20110293402 | GAS TURBINE - A gas turbine including an inner casing and a rotor having rotatable blades with a shroud and a fin, and a cooling arrangement arranged in a cavity in the casing and about the rotatable blade. The blade shroud includes a protrusion extending away from the blade leading edge into the cavity and openings in the cavity wall for a cooling fluid. The protrusion is defined by angles in relation to the flow channel wall. The protrusion affects a vortex flow of cooling fluid entering through the openings and a vortex flow of hot gas entering from the flow channel into the cavity. The double-vortex formation reduces a mixing of the cooling flow with the hot gas flow and increases the efficiency of the cooling arrangement of the blade shroud and cavity walls. | 12-01-2011 |
20120070309 | BLADE FOR A GAS TURBINE - A blade, for a gas turbine, includes a blade airfoil, having a shroud segment arranged on its upper end. The shroud segment together with shroud segments of other blades of a blade row forming an annular shroud which delimits hot gas passage of the gas turbine, and said shroud segment, on sides on which it adjoins adjacent shroud segments of the annular shroud, is provided with upwardly projecting side rails which extend along a side edge, to improve sealing to the hot gas passage. The side rails include rail-parallel or essentially rail-parallel, upwardly open slots through which cooling air, which is introduced via the shroud segment from an interior of the blade airfoil, discharges into the space above the shroud segment. | 03-22-2012 |
Chiara Zingaretti, Siena IT
Patent application number | Description | Published |
---|---|---|
20110110967 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 05-12-2011 |
20130005030 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 (Spy0416) which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 01-03-2013 |
20130202609 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 (Spy0416) which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 08-08-2013 |
20150030625 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 (Spy0416) which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 01-29-2015 |